Prognosis: Understanding Your Outlook

Learning about prognosis can feel overwhelming, especially when the disease is rare and information is scarce. For people living with neuroendocrine tumours of the lung, the expected outcome depends heavily on which subtype they have been diagnosed with. This is not a single disease but rather a family of related conditions, each with its own pattern of growth and response to treatment.^[1]

Typical carcinoid tumours, which are the most common form of lung neuroendocrine tumour, tend to grow slowly and behave in a less aggressive manner. When these tumours are detected early, before they have had the chance to spread to other parts of the body, the five-year survival rate can be as high as 85% to 95%. This means that the vast majority of people diagnosed at an early stage may live five years or more after their diagnosis. However, if the tumour has spread to nearby tissues or distant organs by the time it is found, the outlook becomes less favourable.^[1]

Atypical carcinoid tumours are also slow-growing but are considered more aggressive than typical carcinoids. They carry a slightly higher risk of spreading to other parts of the body, which can complicate treatment. For atypical carcinoids, the five-year survival rate ranges from 40% to 70%, depending on whether the cancer was caught early or had already spread when diagnosed. Like typical carcinoids, the prognosis is better when the tumour is still localised at the time of diagnosis.^[1]

Small cell carcinoma is the most aggressive type of lung neuroendocrine tumour. It grows rapidly and is often diagnosed at an advanced stage, which makes treatment more challenging. The five-year survival rate for small cell carcinoma typically ranges from 20% to 30%. This lower rate is largely because the cancer has often spread by the time symptoms appear, limiting the options for curative treatment.^[1]

It is important to remember that these statistics are estimates based on groups of patients and may not reflect what will happen to any one individual. Advances in medical treatments, including surgery, chemotherapy, radiation therapy, and newer targeted therapies, have improved outcomes for some patients. Each person’s experience is unique, and the best source of information about your personal prognosis is your own healthcare team, who can consider your specific circumstances, overall health, and the particular characteristics of your tumour.^[1]

Natural Progression: How the Disease Develops Without Treatment

If left untreated, neuroendocrine tumours of the lung can progress in different ways depending on the type. The slow-growing forms, such as typical carcinoids, may remain stable for extended periods, sometimes even years. In these cases, the tumour might not cause noticeable symptoms for a long time, and some patients may not even realise they have a problem until it is discovered during a routine check-up or scan for another reason. However, even slow-growing tumours can eventually increase in size and begin to affect the surrounding lung tissue and airways.^[1]

As a tumour grows, it can begin to block or narrow the airways, leading to symptoms such as a persistent cough, wheezing, shortness of breath, or repeated chest infections. These symptoms arise because the tumour physically obstructs the normal flow of air through the lungs. Over time, the tumour may also spread to nearby lymph nodes or other areas within the chest, which can complicate treatment and worsen the prognosis.^[3]

More aggressive forms, such as small cell carcinoma, tend to grow quickly and spread early. Without treatment, these tumours can rapidly invade nearby structures, such as the walls of the chest, the heart, or major blood vessels. They may also spread through the bloodstream to distant organs, including the liver, bones, or brain. This process is known as metastasis, and it can lead to a wide range of symptoms depending on where the cancer has travelled.^[1]

In some cases, lung neuroendocrine tumours produce excess hormones, which can lead to a collection of symptoms known as carcinoid syndrome. This is more common when the tumour has spread to the liver, as the liver normally breaks down these hormones before they circulate widely in the body. When the liver is affected, these hormones can reach high levels, causing symptoms such as skin flushing, diarrhoea, a rapid heartbeat, and wheezing. Although carcinoid syndrome is less common in lung neuroendocrine tumours compared to those starting in the digestive system, it can still occur and significantly affect quality of life if not managed.^[3]

Possible Complications: What Can Go Wrong

Neuroendocrine tumours of the lung can lead to a variety of complications, some of which arise from the tumour itself and others from the treatments used to manage the disease. One of the most significant complications is the spread of cancer to other parts of the body. When the tumour metastasises, it can affect organs such as the liver, bones, or brain, each of which brings its own set of challenges. For example, spread to the bones can cause pain and increase the risk of fractures, while spread to the liver can interfere with its ability to filter toxins from the blood.^[1]

Another complication is the development of carcinoid syndrome, which occurs when the tumour releases large amounts of hormones into the bloodstream. Symptoms can include facial flushing, severe diarrhoea, difficulty breathing, and a rapid or irregular heartbeat. In rare cases, a life-threatening condition called carcinoid crisis can occur, typically during surgery or other medical procedures. This is a sudden and severe episode where large amounts of hormones are released all at once, causing dangerously low blood pressure and other serious symptoms that require immediate medical attention.^[3]

Tumours located in the airways can cause repeated chest infections, as the blockage prevents mucus and bacteria from being cleared effectively. Over time, this can lead to permanent lung damage or scarring. Some patients may also experience bleeding into the lungs, which can cause coughing up of blood—a symptom that should always be reported to a doctor immediately.^[3]

Treatment-related complications can also occur. Surgery, while often the best option for localised tumours, carries risks such as infection, bleeding, and breathing difficulties, especially if a large portion of the lung needs to be removed. Chemotherapy and radiation therapy can cause side effects such as fatigue, nausea, hair loss, and a weakened immune system, which increases the risk of infections. Some targeted therapies and newer treatments may have their own specific side effects, which your healthcare team will monitor closely.^[8]

Impact on Daily Life: Living With the Disease

A diagnosis of neuroendocrine tumour of the lung can affect nearly every aspect of daily life, from physical abilities to emotional wellbeing, relationships, work, and hobbies. The extent of the impact depends on the type and stage of the tumour, the treatments being used, and the individual’s overall health. For some people, especially those with slow-growing tumours that have been caught early, life may continue relatively unchanged, particularly if surgery has been successful. For others, the disease and its treatment can bring significant challenges that require ongoing adjustment.^[14]

Physical symptoms can vary widely. A persistent cough, shortness of breath, and fatigue are common and can make it difficult to perform everyday tasks such as climbing stairs, carrying groceries, or keeping up with children or grandchildren. For those with carcinoid syndrome, unpredictable episodes of flushing and diarrhoea can make it hard to leave the house or participate in social activities. These symptoms can be embarrassing and isolating, leading some people to withdraw from friends and family.^[3]

Emotionally, living with a rare cancer can feel lonely. Many people have never heard of neuroendocrine tumours, and even healthcare professionals outside of specialist centres may have limited experience with them. This can lead to feelings of frustration, fear, and uncertainty about the future. It is common to experience a range of emotions, including anger, sadness, anxiety, and even numbness. Some people describe feeling like they are on an emotional rollercoaster, with good days and bad days that come without warning.^[13]

Work life can also be affected. Frequent medical appointments, fatigue from treatment, and the need to manage symptoms can make it difficult to maintain a full-time job. Some people may need to reduce their hours, change roles, or take extended leave. Others may find that work provides a valuable sense of normalcy and purpose, helping them to focus on something other than their illness. Open communication with employers about your needs and limitations can be helpful, as can exploring financial support options if work becomes impossible.^[14]

Relationships with partners, family, and friends can be strained. Loved ones may not know how to help or what to say, and some may avoid talking about the illness altogether because they find it too difficult. Conversely, some people may want to talk about their cancer constantly, which can feel overwhelming to others. Finding a balance and being honest about what you need from those around you is important. Many patients find that joining a support group, either in person or online, allows them to connect with others who truly understand what they are going through.^[13]

Hobbies and leisure activities may need to be adapted. For example, someone who loved hiking may need to switch to shorter, less strenuous walks. Fatigue and breathlessness can make it hard to enjoy activities that were once a source of joy, which can lead to feelings of loss and grief. Finding new ways to stay engaged and fulfilled, even if on a smaller scale, can help maintain a sense of identity and purpose.^[14]

Diet and nutrition can also become a focus, especially for those with carcinoid syndrome. Certain foods and drinks, such as aged cheese, smoked meats, chocolate, red wine, and beer, contain high levels of amines—compounds that can trigger flushing, diarrhoea, and other uncomfortable symptoms. Avoiding these foods and eating smaller, more frequent meals can help manage symptoms and improve quality of life.^[15]

Support for Family: Helping Loved Ones Through Clinical Trials and Beyond

Families play a crucial role in supporting someone with neuroendocrine tumour of the lung, particularly when it comes to navigating the healthcare system and exploring treatment options such as clinical trials. Clinical trials are research studies that test new treatments or new ways of using existing treatments to see if they are safe and effective. For people with rare cancers like lung neuroendocrine tumours, clinical trials may offer access to cutting-edge therapies that are not yet widely available.^[1]

Understanding clinical trials can feel daunting, but families can help by learning about the basics. Clinical trials have strict rules about who can join, known as eligibility criteria. These might include the type and stage of cancer, previous treatments received, and overall health. Not everyone will be eligible for every trial, and that is perfectly normal. Families can assist by helping the patient gather medical records, making notes during appointments, and asking questions about potential trials when meeting with the healthcare team.^[1]

Finding relevant clinical trials can be challenging, especially for rare diseases. Families can support their loved one by searching online databases of clinical trials, asking the patient’s specialist about ongoing studies, or reaching out to patient advocacy organisations that focus on neuroendocrine tumours. These organisations often have information about trials and can help connect patients with researchers. Sometimes, clinical trials are only available at certain hospitals or research centres, which may mean travelling long distances. Families can help by researching logistics, such as accommodation, transport, and financial support for travel.^[1]

It is important for families to understand that participating in a clinical trial is always voluntary. The patient has the right to withdraw at any time, and choosing not to join a trial will not affect the standard care they receive. Families can help by encouraging open and honest discussions about the potential benefits and risks, and by supporting the patient’s decision, whatever it may be. Sometimes, the decision is not just about medical factors but also about quality of life, personal values, and what feels right for that individual.^[1]

Beyond clinical trials, families can support their loved one in many practical and emotional ways. Attending medical appointments together can help ensure that important information is not missed and can provide emotional support during difficult conversations. Helping with everyday tasks such as cooking, cleaning, or childcare can ease the burden on someone who is feeling unwell or fatigued. Simply being there to listen, without trying to fix everything, can be incredibly valuable.^[14]

Families should also take care of their own wellbeing. Caring for someone with cancer can be exhausting and emotionally draining. It is important to ask for help from other family members, friends, or professional services, and to make time for self-care. Joining a support group for caregivers or talking to a counsellor can provide a space to share feelings and gain practical advice from others in similar situations.^[13]